Literature Review
All posts tagged with “Clinical News | Pharmacy & Medication News.”
‘A playbook for best practices’: ASCO and COA release updated Oncology Medical Home Standards
09/16/25 at 03:00 AM‘A playbook for best practices’: ASCO and COA release updated Oncology Medical Home Standards The ASCO Post; by ASCO (American Society of Clinical Oncology); 9/10/25 ASCO and the Community Oncology Alliance (COA) have released updated standards for its Oncology Medical Home (OMH) certification program, which were initially codified and published in 2021. The 2021 systematic literature review focused on the topics of OMH model of care, clinical pathways, and survivorship care plans. Among the 2025 updates are new standards that address “just culture” and safety in oncology, multidisciplinary team management, and geriatric assessment.
Evaluating the clinical reasoning of generative AI in palliative care: A comparison with five years of pharmacy learners
09/16/25 at 03:00 AMEvaluating the clinical reasoning of generative AI in palliative care: A comparison with five years of pharmacy learners Journal of Palliative Medicine; by Mikaila T Lane, Toluwalase A Ajayi, Kyle P Edmonds, Rabia S Atayee; 9/9/25Context: Artificial intelligence (AI), particularly large language models (LLMs), offers the potential to augment clinical decision-making, including in palliative care pharmacy, where personalized treatment and assessments are important. Conclusions: While LLMs [large language models] show potential for augmenting clinical decision-making, their limitations in patient-centered care highlight the necessity of human oversight and reinforce that they cannot replace human expertise in palliative care. This study was conducted in a controlled research setting, where LLMs were prompted to answer clinical reasoning questions despite default safety restrictions.
[UK] Does non-beneficial nasogastric tube feeding occur during end-of-life care? An audit of outcomes for those with a malnutrition universal screening tool score of 2
09/13/25 at 03:05 AM[UK] Does non-beneficial nasogastric tube feeding occur during end-of-life care? An audit of outcomes for those with a malnutrition universal screening tool score of 2Journal of Palliative Medicine; by Ross Andrew James Webster, Moitree Banerjee, Rachel King, Rosana Pacella, Antonina Pereira; 8/25The consideration of artificial nutrition and hydration (ANH) is recommended for individuals with reduced nutritional intake. However, placing long-term nonoral feeding tubes is not appropriate in those with advanced dementia or if the individual is likely to die imminently—“within hours or days”. In some instances, the provision of ANH in the weeks leading up to death may be considered a “Non-Beneficial Treatment.” In [this study a] total [of] 40 (47.6%) of 84 NGT [nasogastric tube]-flagged individuals were deceased within six months. Conclusions: NGT insertions in this cohort have a high likelihood of being considered “non-beneficial.”
The rise of psychedelic therapeutics for end-of-life care: A new frontier in mental health and palliative medicine
09/08/25 at 03:00 AMThe rise of psychedelic therapeutics for end-of-life care: A new frontier in mental health and palliative medicine AI Invest; by Julian Cruz; 9/3/25 Aime Summary
Risky prescribing and the epidemic of deaths from falls
09/06/25 at 03:15 AMRisky prescribing and the epidemic of deaths from fallsJAMA Health Forum; Thomas A. Farley; 8/25In 2023, more than 41,000 individuals older than 65 years died from falls. More importantly, the mortality rate for falls among older adults in the US has more than tripled during the past 30 years. Drugs that cause drowsiness or impaired balance or coordination have been called fall risk–increasing drugs (FRIDs). The list of FRIDs is long and includes drugs such as β-blockers and anticholinergics, as well as proton pump inhibitors that may increase the risk of an injury during a fall. Four categories (opioids, benzodiazepines, gabapentinoids, and antidepressants) of central nervous system–active FRIDs are particularly concerning because of a combination of surging use and a strong association with falls.
Reconsidering neuraxial analgesia at end of life: Clinical, ethical, and socioeconomic perspectives
09/06/25 at 03:10 AMReconsidering neuraxial analgesia at end of life: Clinical, ethical, and socioeconomic perspectivesInterventional Pain Medicine; Sanjeet Narang , Jason Yong , David Hao, 9/25Pain is one of the most prevalent and distressing symptoms experienced by patients nearing end of life, particularly among those with cancer. While systemic opioids are the mainstay of treatment, their limitations necessitate consideration of alternative strategies. Neuraxial analgesia, including epidural and intrathecal drug delivery systems, offers targeted pain relief with reduced systemic burden. Yet despite supportive data, these interventions remain underutilized due to clinical, ethical, logistical, and socioeconomic barriers. This article examines the complex decision-making involved in offering neuraxial analgesia at the end of life, weighing risks and benefits, shifting patient goals, and the challenges of care coordination.
Why palliative care is more than just end-of-life support
09/04/25 at 03:00 AMWhy palliative care is more than just end-of-life support MedPageToday's KevinMD.com; by Dr. Vishal Parackal; 9/1/25 ... Palliative care as a system requires strong interpersonal and cross-specialty communication for smooth functioning, as patients may require expert opinions from different fields to optimize their treatment plan. Patient education for systemic follow-ups and establishing a baseline of knowledge regarding their diagnosis and potential danger signs helps create a better environment for holistic care. While we focus on the physical aspects of care and diagnosis, we often fail to realize the psychological and mental impact that such conditions can have on the patient and their family. ... The opportunity to make a meaningful difference in patients’ lives by easing their suffering and enhancing their quality of life is profoundly fulfilling. ... Editor's Note: Excellent descriptions of palliative care.
How health systems are saving money with centralized pharmacies
08/28/25 at 03:00 AMHow health systems are saving money with centralized pharmaciesModern Healthcare; by Caroline Hudson; 8/27/25Health systems are centralizing pharmacy operations to cut costs. Many systems are bringing drug inventory, fulfillment and distribution under one roof. Centralization can help systems navigate a rapidly changing pharmaceutical industry.
DOJ probing UnitedHealth’s Optum Rx, alongside Medicare practices
08/28/25 at 03:00 AMDOJ probing UnitedHealth’s Optum Rx, alongside Medicare practicesModern Healthcare; by Chris Strohm, John Tozzi; 8/26/25The U.S. Justice Department’s criminal division is digging into UnitedHealth Group Inc.’s prescription management services as well as how it reimburses its own doctors under an ongoing probe into the firm’s operations, according to people familiar with the matter. The previously unreported areas of the probe show the scrutiny is broader than was known and goes beyond an inquiry into possible Medicare fraud. Investigators are looking into business practices at the company’s pharmacy benefit manager Optum Rx, in addition to the physician payments, said the people, who asked not to be identified discussing a confidential matter.
Transformative impacts of clinical pharmacists in hospice care
08/27/25 at 03:10 AMTransformative impacts of clinical pharmacists in hospice careMcKnight's Home Care; by Deanna Douglass; 8/20/25Hospice represents a unique niche in the healthcare system, with goals and best practices that differ significantly from those of curative care. One defining characteristic of hospice is the use of medications to manage symptoms rather than improve or restore health. Pharmacists with specialized hospice and palliative care expertise have long played a vital role in enhancing quality of life for patients in their final days. From managing complex symptoms to ensuring cost-effective prescribing, these dedicated professionals are indispensable partners within interdisciplinary care teams and for hospice leadership. [This article discusses:]
Proportional sedation for persistent agitated delirium in palliative care-A randomized clinical trial
08/23/25 at 03:05 AMProportional sedation for persistent agitated delirium in palliative care-A randomized clinical trialJAMA Oncology; David Hui, Allison De La Rosa, Jaw-Shiun Tsai, Shao-Yi Cheng, Egidio Del Fabbro, Anita Thankam Thomas Kuzhiyil, Kendra Rowe, Ahsan Azhar, Thuc Nguyen, Michael Tang, Chien-An Yao, Hsien-Liang Huang, Jen-Kuei Peng, Wen-Yu Hu, Sonal Admane, Rony Dev, Minxing Chen, Patricia Bramati, Sanjay Shete, Eduardo Bruera; 7/25Neuroleptic and benzodiazepine medications are often considered for patients with persistent agitated delirium in the last days of life; however, the risk-to-benefit ratio of these medications is ill-defined and benzodiazepine medications have not been compared to placebo. The results of this randomized clinical trial indicate that proactive use of scheduled sedatives, particularly lorazepam-based regimens, may reduce persistent restlessness and/or agitation in patients with advanced cancer and delirium in the palliative care setting.
[Iceland] Medication causes and treatment of delirium in patients with and without dementia
08/23/25 at 03:05 AM[Iceland] Medication causes and treatment of delirium in patients with and without dementiaBrain and Behavior; by Anita Elaine Weidmann, Rut Matthíasdóttir, Guðný Björk Proppé, Ivana Tadić, Pétur Sigurdur Gunnarsson, Freyja Jónsdóttir; 7/25This summary offers the most detailed summary of medication-related information for delirium in patients with and without dementia to support prescribing decisions. While the detailed results can be used to support a multicomponent approach to delirium care, they also support the call for categorizing delirium into distinct etiological subgroups. The effect of medication on gut microbiome diversity and composition should be considered.
Palliative care plays an essential role in heart failure care
08/18/25 at 03:00 AMPalliative care plays an essential role in heart failure care Cardiovascular Business; by Michael Walter; 8/13/25 Palliative care should play a significant role in the day-to-day management of heart failure (HF) patients, according to new recommendations from the Heart Failure Society of America (HFSA). HF patients are associated with high mortality and a considerably worse quality of life, the group wrote. Care teams should be doing everything in their power to help patients control their symptoms and live the best lives possible. The HFSA guidance is available in full in the Journal of Cardiac Failure. ... “When using a guide, conversations are more likely to be feasible, acceptable and associated with positive experiences for both patients and clinicians,” the authors wrote.
[Belgium] Christian perspectives on palliative sedation: A literature study
08/16/25 at 03:55 AM[Belgium] Christian perspectives on palliative sedation: A literature studyBMC Palliative Care; Jonathan Lambaerts, Bert Broeckaert; 7/25Overall, there is a positive but cautious attitude towards palliative sedation in the four major Christian traditions. All recognise that palliative sedation can help alleviate patient suffering. They remain cautious in their support, however, as they consider the line between palliative sedation and life-ending treatments (e.g. euthanasia) to be too blurred. Moreover, the Christian traditions are aware that lowering the level of consciousness is not without its problems.
Caring for every breath: Carolina Caring Advanced Lung Care Program launched August 1st
08/11/25 at 03:00 AMCaring for every breath: Carolina Caring Advanced Lung Care Program launched August 1st Carolina Caring, Newton, NC; Press Release; 8/8/25 A specialized lung care program providing care for complex respiratory conditions will bring needed comfort and support to many individuals. Launched on August 1st, 2025, Carolina Caring’s Advanced Lung Care Program helps patients receive the personalized care they need for their advanced respiratory illness at end of life, while remaining comfortably at home—leading to a reduction of hospitalizations and improved quality of life for patients and their families.
Creating user personas to represent the needs of dementia caregivers who support medication management at home: Persona development and qualitative study
08/09/25 at 03:35 AMCreating user personas to represent the needs of dementia caregivers who support medication management at home: Persona development and qualitative studyJMIR Aging; by Anna Jolliff, Priya Loganathar, Richard J Holden, Anna Linden, Himalaya Patel, Jessica R Lee, Aaron Ganci, Noll Campbell, Malaz Boustani, Nicole E Werner; 7/25Caregiver-assisted medication management plays a critical role in promoting medication adherence and quality of life for people living with Alzheimer disease or related dementias (ADRD). Caregivers in this study demonstrated a range of characteristics and values that informed their approach to medication management. They used a combination of technology-based strategies and strategies situated in their physical environments to manage medications. The personas created can be used to inform interventions, such as digital tools, that address caregivers' unmet needs.
Lorazepam reduced restlessness, agitation in cancer patients with delirium
08/08/25 at 03:00 AMLorazepam reduced restlessness, agitation in cancer patients with delirium: Patients were also less likely to require any rescue medications MedPage Today; by Mike Bassett; 8/5/25Use of lorazepam-based regimens reduced persistent restlessness and agitation associated with end-of-life delirium in cancer patients, a randomized study showed.Key Takeaways:
Study reveals how medication side effects can lead to dangerous medication cycles in adults 65+
08/05/25 at 03:00 AMStudy reveals how medication side effects can lead to dangerous medication cycles in adults 65+ McKnights Long-Term Care News; by Donna Shryer; 7/31/25 When doctors treat drug side effects as new illnesses, older adults may be prescribed even more medications — a cycle known as a “prescribing cascade.” A new study says this prescribing cycle can increase the risk of harm. Guest Editor's Note, Drew Mihaylo, PharmD: Practicing clinical vigilance regarding medication utilization is essential at any stage of illness. Prescribing cascades are common, under-recognized and often harmful. Approaching the emotional topic of medication change must be done with compassion and sensitivity tied to patient specific goals of care. Creativity to this end has been a focus of mine for sometime now as a clinical pharmacist serving serious illness patients nationally.
Study reveals how medication side effects can lead to dangerous medication cycles in adults 65+
08/04/25 at 03:00 AMStudy reveals how medication side effects can lead to dangerous medication cycles in adults 65+ McKnights Long-Term Care News; by Donna Shryer; 7/31/25 When doctors treat drug side effects as new illnesses, older adults may be prescribed even more medications — a cycle known as a “prescribing cascade.” A new study says this prescribing cycle can increase the risk of harm. A prescribing cascade example cited in the research involves older patients taking calcium channel blockers for blood pressure control, which can cause ankle swelling side effects. Instead of first adjusting the blood pressure drug, some doctors immediately prescribe a diuretic to reduce the swelling — which for some, can create an unnecessary drug pair.
Telemedicine special registrations for controlled substances
08/02/25 at 03:00 AMTelemedicine special registrations for controlled substancesJAMA Health Forum; by Jacob T. Kannarkat, John Torous, Joseph T. Kannarkat; 7/25Since the COVID-19 pandemic, the requirement for in-person evaluation of patients prior to the prescribing of controlled substances via telehealth, as established by the Ryan Haight Online Pharmacy Consumer Protection Act (Ryan Haight Act), has remained provisionally held. The Drug Enforcement Agency (DEA) previously proposed rulemaking to reintroduce the in-person patient evaluation requirement, as some unscrupulous clinicians and companies took advantage of this deregulated environment to overprescribe controlled substances. However, these flexibilities were extended through December 31, 2025, after the public voiced concerns over possible care disruptions in a landscape increasingly dependent on telehealth. Now, the DEA aims to compromise on prescribing flexibility with more practical enforcement measures.
BetterRX receives strategic investment from BVP Forge to transform hospice pharmacy care nationwide and appoints Tim Tannert as CEO
07/28/25 at 03:00 AMBetterRX receives strategic investment from BVP Forge to transform hospice pharmacy care nationwide and appoints Tim Tannert as CEOBusinesswire press release; 7/25/25BetterRX, the leading hospice pharmacy platform, today announced a strategic growth investment from BVP Forge, to accelerate its future growth. BetterRX also announced the appointment of Tim Tannert as its new CEO.
Facing new CMS pressure, providers should audit mental health diagnoses, prescriptions: expert
07/24/25 at 03:00 AMFacing new CMS pressure, providers should audit mental health diagnoses, prescriptions: expert McKnights Long-Term Care News; by Kimberly Marselas; 7/22/25 As reported in McKnight’s Long-Term Care News on July 23, “Nursing homes should be auditing documentation for all residents with mental health disorders to ensure their diagnoses are compliant with new federal guidance, a well-known clinical reimbursement recommended Tuesday. Leigh Ann Frick, president of Care Navigation Consulting, made that suggestion while reviewing updated Long-Term Care Surveyor Guidance that went into effect in late April. At over 900 pages, the new manual and appendixes have left many providers still navigating the changes and how best to respond to them. When it comes to giving antipsychotic medications, diagnosing patients with disorders that require them, or identifying and responding to any other patient needs, the guidance puts new emphasis on the use of professional standards, Frisk explained. Guest Editor’s Note, Judi Lund Person: For nursing home residents who have elected the Medicare hospice benefit, this information may apply. Diagnosing mental health issues, prescribing, and documenting based on professional standards is an important component in the updated Long-Term Care Surveyor guidance issued in April.
[Canada] Electronic decision support for deprescribing in older adults living in long-term care-A stepped-wedge cluster randomized trial
07/19/25 at 03:05 AM[Canada] Electronic decision support for deprescribing in older adults living in long-term care-A stepped-wedge cluster randomized trialJAMA Network Open; Emily G. McDonald, MD, MSc; Justine L. Estey, MSc; Cody Davenport, MSc; Émilie Bortolussi-Courval, RN; Jeffrey Gaudet, MSc; Pierre Philippe Wilson Registe, MSc, MPH; Todd C. Lee, MD, MPH; Carole Goodine, PharmD; 5/25Potentially inappropriate prescribing (PIP) occurs when medications that carry a higher risk of harm than benefit are prescribed. It occurs more often among older adults in the setting of polypharmacy (taking multiple medications) and is costly and harmful. PIP and potentially inappropriate medications (PIMs) contribute to excess adverse drug events, such as falls, fractures, cognitive decline, hospitalization, and death [and] the problem is more pronounced for older adults living in nursing homes (long-term care [LTC] homes). Depending on the screening criteria used, in some studies, the prevalence ranges from 67.8% to 87.7% of nursing home residents. Electronically generated, individualized reports that contained prioritized opportunities for deprescribing in older adults were paired with preexisting quarterly medication reviews [and] this study found that electronic decision support paired with the usual workflow could render the deprescribing process scalable and effective.
When less is more: Addressing polypharmacy in high-risk populations
07/08/25 at 03:00 AMWhen less is more: Addressing polypharmacy in high-risk populations Pharmacy Times; by Andrew E. Esch, MD, MBA and Alain Hipensteele; 7/7/25 As digital health tools and artificial intelligence (AI)–powered clinical decision support systems become increasingly embedded in pharmacy workflows, pharmacists are gaining new opportunities to identify and address the risks of polypharmacy—particularly in high-risk populations such as older adults and those receiving palliative care. At the same time, evolving deprescribing guidelines and ongoing drug shortages have underscored the need for coordinated, patient-centered medication management strategies. In this interview with Pharmacy Times®, Andrew E. Esch, MD, MBA, director of the Palliative Care Program Development at the Center to Advance Palliative Care, discusses how pharmacists are using emerging technologies to streamline medication reviews, reduce therapeutic duplication, and engage caregivers in deprescribing conversations.
The role of an inpatient hospice and palliative clinical pharmacist in the interdisciplinary team
07/02/25 at 03:00 AMThe role of an inpatient hospice and palliative clinical pharmacist in the interdisciplinary team Texas Medical Center Documents, published by the American Journal of Hospice and Palliative Medicine; by Jetavia Jones Moody, Ivy O. Poon, and Ursula K. Braun; 6/30/25 Palliative care is a specialized health care service for individuals with serious illness at any stage and can be provided in any setting. Current national consensus developed by palliative care experts recommends the inclusion of pharmacists in an interdisciplinary team (IDT) to provide quality palliative care. However, national registry data report that less than 10% of inpatient palliative teams in the U.S. have a clinical pharmacist. Clinical pharmacists have an impactful role in palliative patients' quality of life by optimizing symptom management, deprescribing, and providing education to the palliative care team as well as patients and their families.